Vaccination with a bivalent vaccine against Covid-19 focuses, in its first phase, on people over 70 years of age, immunocompromised.promeindigenous, riverside and quilombola communities.
ADVERTISING
In phase 2, people aged between 60 and 69 years old enter; in phase 3, pregnant and postpartum women; and in phase 4, health professionals.
Two bivalent vaccines, produced by the Pfizer laboratory, received authorization from the National Health Surveillance Agency (Anvisa) for emergency use, and are indicated as a single booster dose for children and adults, two months after completing the primary vaccination schedule, or as the last booster dose.
Campaign continues normally
The Ministry of Health reinforces that monovalent vaccines against Covid-19 are still available in basic health units (UBS) for the general population and are classified as “highly effective against the disease”, guaranteeing a high level of immunity and preventing mild cases. , serious illnesses and deaths from the disease.
ADVERTISING
“The application of bivalent vaccines does not mean that monovalent vaccines do not continue to protect. They continue to protect, even for the Ômicron variant, but, of course, with the possibility of a vaccine designed more specifically for the circulating variant, the tendency is to have a better response”, reinforced the director of the Brazilian Society of Immunizations, Juarez Cunha.
@curtonews Oh how delicious, let's get vaccinated! The first stage of the vaccination plan against # Covid19 ♬ original sound – Curto News
(Source: Agência Brasil)
See also:
